Literature DB >> 10328911

Cooling and freezing damage platelet membrane integrity.

T J Reid1, V F LaRussa, G Esteban, M Clear, L Davies, S Shea, M Gorogias.   

Abstract

Cytoskeletal rearrangements and a membrane lipid phase transition (liquid crystalline to gel) occur in platelets on cooling from 23 to 4 degrees C. A consequence of these structural alterations is irreversible cellular damage. We investigated whether platelet membrane integrity could be preserved by (a) previously studied combinations of a calcium chelator (EGTA) and microfilament stabilizer (cytochalasin B) with apparent benefit in protecting platelets from cooling injury or (b) agents of known benefit in protecting membranes and proteins from freezing injury. Platelet function and activation before and after freezing or cooling were measured by agglutination with ristocetin, aggregation with thrombin or ADP, platelet-induced clot retraction (PICR), and expression of P-selectin. Platelets were loaded with 10 nM fluorescein diacetate. After freezing or cooling, the preparations were centrifuged and the supernatant was measured for fluorescein. For cooling experiments, fresh platelets were chilled at 4 degrees C for 1 to 21 days with or without the combination of 80 microM EGTA/AM and 2 microM cytochalasin B (EGTA/AM-CytoB) and then warmed rapidly at 37 degrees C. For freezing experiments, 5% dimethyl sulfoxide (Me2SO) or 5 mM glycerol were added to fresh platelets. The preparations were then frozen at -1 degrees C/min to -70 degrees C and then thawed rapidly at 37 degrees C. Platelet membrane integrity, as measured by supernatant levels of fluorescein, correlated inversely with platelet function. Chilling platelets at 4 degrees C with EGTA/AM-CytoB showed a gradual loss of membrane integrity, with maximum loss reached on day 7. The loss of membrane integrity preceded complete loss of function as demonstrated by PICR. In contrast, platelets chilled without these agents had complete loss of membrane integrity and function after 1 day of storage. Freezing platelets in Me2SO resulted in far less release of fluorescein than did freezing with or without other cryoprotectants (P < 0.001). This result correlated with enhanced function as demonstrated by PICR and supports earlier observations that Me2SO protects platelet membranes from freezing injury. Release of fluorescein into the surrounding medium reflected loss of membrane integrity and function in both cooled and frozen platelets. Membrane cytoskeletal rearrangements are linked to membrane changes during storage. These results may be generally applicable to the study of platelet storage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328911     DOI: 10.1006/cryo.1999.2164

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  9 in total

1.  Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.

Authors:  Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Serge El-Khoury; Chandra Krishnan; Mark G Luciano
Journal:  Neurochem Res       Date:  2011-06-04       Impact factor: 3.996

2.  Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application.

Authors:  Dinara Samarkanova; Luciano Rodríguez; Joaquim Vives; Ruth Coll; Elisabet Tahull; Carmen Azqueta; Elena Valdivia; Margarita Codinach; Elisenda Farssac; Jesus Gaitan; Jose R Escudero; Sergio Querol
Journal:  Blood Transfus       Date:  2020-04-03       Impact factor: 3.443

3.  Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.

Authors:  Christine Schwienbacher; Luisa Foco; Anne Picard; Eloina Corradi; Alice Serafin; Jörg Panzer; Stefano Zanigni; Hagen Blankenburg; Maurizio F Facheris; Giulia Giannini; Marika Falla; Pietro Cortelli; Peter P Pramstaller; Andrew A Hicks
Journal:  J Mol Neurosci       Date:  2017-05-24       Impact factor: 3.444

Review 4.  A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?

Authors:  E Hormbrey; P Gillespie; K Turner; C Han; A Roberts; D McGrouther; A L Harris
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Storage temperature determines platelet GPVI levels and function in mice and humans.

Authors:  Jeffrey Miles; S Lawrence Bailey; Ava M Obenaus; Molly Y Mollica; Chomkan Usaneerungrueng; Daire Byrne; Lydia Fang; Jake R Flynn; Jill Corson; Barbara Osborne; Katie Houck; Yi Wang; Yu Shen; Xiaoyun Fu; Jing-Fei Dong; Nathan J Sniadecki; Moritz Stolla
Journal:  Blood Adv       Date:  2021-10-12

6.  Influence of Cellular Composition and Exogenous Activation on Growth Factor and Cytokine Concentrations in Canine Platelet-Rich Plasmas.

Authors:  Samuel P Franklin; Kate E Birdwhistell; Alena Strelchik; Bridget C Garner; Benjamin M Brainard
Journal:  Front Vet Sci       Date:  2017-04-05

Review 7.  Platelet Biochemistry and Morphology after Cryopreservation.

Authors:  Katrijn R Six; Veerle Compernolle; Hendrik B Feys
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements.

Authors:  Milton Ashworth; Benjamin Small; Lucy Oldfield; Anthony Evans; William Greenhalf; Christopher Halloran; Eithne Costello
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

9.  Platelets confound the measurement of extracellular miRNA in archived plasma.

Authors:  Adam J Mitchell; Warren D Gray; Salim S Hayek; Yi-An Ko; Sheena Thomas; Kim Rooney; Mosaab Awad; John D Roback; Arshed Quyyumi; Charles D Searles
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.